Background: After the invasion of Ukraine, neighbouring countries were forced to find systemic solutions to provide medical care to those fleeing the war, including children, as soon as possible. In order to do this, it is necessary to know the communication problems with refugee minors and find proposals for their solutions. Methods: A systematic review of the literature from 2016 to 2022 was conducted according to PRISMA criteria. Results: Linguistic diversity and lack of professional readiness of teachers are the main constraints hindering the assistance of refugee children in schools. Problems during hospitalization include lack of continuity of medical care and lack of retained medical records. Solutions include the use of the 3C model (Communication, Continuity of care, Confidence) and the concept of a group psychological support program. Conclusions: In order to provide effective assistance to refugee minors, it is necessary to create a multidisciplinary system of care. It is hoped that the lessons learned from previous experiences will provide a resource to help refugee host countries prepare for a situation in which they are forced to provide emergency assistance to children fleeing war.

Introduction: Schizophrenia is a disease that affects approximately 1% of the population. It begins in adult humans. It turns out that there are factors that predispose to schizophrenia, and by modifying your lifestyle, you can reduce the likelihood of its occurrence. One of such factors is the diet and microelements, macronutrients and vitamins that we consume every day. The aim of the study: The aim of this study was to find out the relationship between the diet, microelements, macronutrients, vitamins and the schizophrenia disease. Material and method: The research of articles was done in the websites such as PubMed and Google Scholar. Description of the state of knowledge: Ketogenic and gluten-free diet are promising tools in decreasing the symptoms of and treating schizophrenia. Micro-and macroelement imbalances are present in schizophrenic patients, but their correlation with development of schizophrenia is not clear. Folate, vitamin D and vitamin B12 supplementation could prove useful in the treatment. Summary: There are many studies that try to combine the implications of a balanced diet and the proper supply of elements and their impact on schizophrenia's occurrence and symptomology. Still, further investigation of these topics is needed to provide the most suitable guidelines and applications of proper nutrition of schizophrenic patients.

Introduction: Depression is a mental disorder that is increasingly being diagnosed in middle and more developed countries (MDC). Symptoms of depression in patients with severe depressive disorder (MDD) include sadness, regret, negative thoughts, anxiety, and more.The aim of the study: The aim of the study was to summarize the latest research (from 2020) on factors related to the occurrence of depression, as well as the current findings on depression (also those related to the COVID-19 pandemic).Material and method: For this purpose, scientific search engines such as PubMed and Google Scholar were used.Description of the state of knowledge: In 2020, apart from research on pathomechanisms and environmental factors, a large part of the research focused on the COVID-19 pandemic as a risk factor for the development of depression symptoms. Many studies from different parts of the world have confirmed that a pandemic can have a significant impact on the occurrence of depression. Summary: There are many factors that can cause depression and it is important to keep them in mind both in everyday life and in clinical practice. Studies from various parts of the world have shown that the COVID-19 pandemic has exacerbated the experience of depressive symptoms, also in those who have not yet been diagnosed with MDD. The degree of severity of depressive symptoms depended on such factors as: financial situation, social isolation.

The aim of the study is to systematize the knowledge about xylometazoline and oxymetazoline - commonly used nasal sprays with sympathicomimetic effect, mainly directly on α-adrenergic receptors [1]. A review of recent reports on possible side effects and new therapeutic options will be presented. Results: Over several years, reports have been published regarding descriptions of unusual cases of side effects, such as angina attack [4], a case of respiratory failure in a newborn [5], ischemic stroke [6], or anaphylactic reaction during routine surgery. In experiments using rats, on the other hand, it has been shown that these substances can also cause increased inflammation of the lower respiratory tract [7], as well as numerous ophthalmic problems [8]. Recent reports also suggest new uses for xylometazoline and oxymetazoline. In combination with lidocaine, an intranasal solution of xylometazoline has shown efficacy in the anesthesia of maxillary teeth in patients with minor carious lesions [9], and a beneficial therapeutic combination of oxymetazoline and dye laser (PDL) has also been reported for the treatment of rosacea, among others [10]. Conclusions: Although imidazoline derivatives were admitted to the drug list decades ago, still their pharmacological potential has not been fully exploited. Finding applications of these drugs in dermatology and dentistry may not only improve the efficacy and comfort of treatment, but also significantly reduce the costs of the whole therapy. The aforementioned reports on the side effects of xylometazoline and oxymetazoline should not be forgotten. It is possible that the presented examples will increase awareness to use these drugs with more respect, according to the recommendations on the leaflet.

Introduction and aims of the study: The aim of this study is to present recent reports on the treatment and therapy of schizophrenia and bipolar disorder (ChAD). The current treatment of patients affected by these diseases is difficult and unsatisfactory, therefore it is necessary to find new therapeutic options that will improve the effectiveness of treatment For the purpose of this study, scientific papers were reviewed using the Google Scholar search engine covering studies from 2016 to 2021. A dozen papers covering the scope of the publication were selected. Results: In the treatment of schizophrenia, the use of cannabinoids is of greatest interest due to the action of the preparations on the endocannabinoid system. In the treatment of ChaD, promising reports have been published on the therapy with aripiprazole and the need to improve its use in the treatment of both akathisia and agitation. Furthermore, from the fact that abnormalities of calcium signalling are considered a possible pathophysiological process in ChAD, it has been suggested that calcium channel L antagonists may be potential therapeutic agents in bipolar affective disorder. One study also demonstrated the potential use of vortioxetine in the treatment of patients with a depressive episode. Conclusions: The results of recent studies on the treatment of schizophrenia and ChAD cited in this paper offer the prospect of creating treatment regimens that are more effective and targeted in the aforementioned diseases. However, further randomised trials are needed to confirm the effective use of the cited drugs in the treatment of these diseases.